ARCHIVES

ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 37 | October 9, 2009

Download PDF Visit The Full Archive

Related Articles

Cell Therapeutics To Appeal FDA Decision on Pixantrone.

September 17, 2010

Cervix Moves Significantly During Radiation for Cancer

February 27, 2009

Final Issue Of ‘77

December 16, 1977

Court Could Determine Future of Clinical Trials in Abigail Alliance Case.

February 9, 2007

In Brief: Bailes Succeeds Lichor As ASCO President; Einhorn Is President-Elect; Durant Honored

May 21, 1999

Almost Half of Faculty on IRBs Have Industry Ties, Study Finds

September 26, 2003